Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: Role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes

被引:0
|
作者
Gu, J
Zhang, QY
Genter, MB
Lipinskas, TW
Negishi, M
Nebert, DW
Ding, XX
机构
[1] New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Environm Dis Prevent, Lab Human Toxicol & Mol Epidemiol, Albany, NY 12201 USA
[2] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA
[4] Univ Cincinnati, Med Ctr, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA
[5] NIEHS, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, Res Triangle Pk, NC 27709 USA
[6] SUNY Albany, Sch Publ Hlth, Albany, NY USA
来源
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1998年 / 285卷 / 03期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolic activation of two known olfactory mucosal (OM) toxicants, acetaminophen (AP) and 2,6-dichlorobenzonitrile (DCBN), was examined with mouse liver and OM microsomes and purified, heterologously expressed mouse CYP2A5 and CYP2G1. In reconstituted systems, both isoforms were active in metabolizing DCBN and AP to metabolites that formed protein adducts. The formation of DCBN- or AP-protein adducts and other AP metabolites, including 3-hydroxy-AP and, in the presence of glutathione, AP-glutathione conjugate, was also detected in OM microsomal reactions and to a much greater extent than in liver microsomes. Evidence was obtained that CYP2A5 and CYP2G1 play major roles in mouse OM microsomal metabolic activation of DCBN and AP. Immunoblot analysis indicated that CYP2A5 and CYP2G1 are abundant P450 isoforms in OM microsomes. OM microsomal AP and DCBN metabolic activation was inhibited by 5- and 8-methoxsalen, which inhibit both CYP2A5 and CYP2G1, and by an inhibitory anti-CYP2A5 antibody that also inhibits CYP2G1. In addition, the roles of CYP1A2 and CYP2EI in the OM bioactivation of AP and DCBN were ruled out by comparing activities of acetone-treated mice or Cyp1a2(-/-) mice with those of control mice. Thus, CYP2A5 and CYP2G1 may both contribute to the known OM-selective toxicity of AP and DCBN. Further analysis of the kinetics of AP and DCBN metabolism by the purified P450s suggested that CYP2A5 may play a greater role in OM microsomal metabolism of AP, whereas their relative roles in DCBN metabolism may be dose dependent, with CYP2G1 playing more important roles at low substrate concentrations.
引用
收藏
页码:1287 / 1295
页数:9
相关论文
共 35 条
  • [1] Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: Essential roles of CYP2A5 and target-tissue metabolic activation
    Xie, Fang
    Zhou, Xin
    Behr, Melissa
    Fang, Cheng
    Horii, Yuichi
    Gu, Jun
    Kannan, Kurunthachalam
    Ding, Xinxin
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 249 (01) : 101 - 106
  • [2] Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse
    Genter, MB
    Liang, HC
    Gu, J
    Ding, XX
    Negishi, M
    McKinnon, RA
    Nebert, DW
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1819 - 1826
  • [3] Characterization of CYP2A4 and CYP2A5 responsible for coxidation of nicotine in mouse liver microsomes
    Miyazaki, M
    Yamazaki, H
    Kimura, M
    Kamataki, T
    DRUG METABOLISM REVIEWS, 2002, 34 : 54 - 54
  • [4] The activities of Cyp1a1 and Cyp2a5 in mouse brain
    Ozdamar, E. D.
    Iscan, M.
    Eke, B. C.
    TOXICOLOGY LETTERS, 2005, 158 : S208 - S208
  • [5] cDNA cloning and heterologous expression of mouse CYP2G1
    Hua, ZC
    Ding, XX
    ENZYME ENGINEERING XIV, 1998, 864 : 309 - 312
  • [6] cDNA cloning, heterologous expression, and characterization of mouse CYP2G1, an olfactory-specific steroid hydroxylase
    Hua, ZC
    Zhang, QY
    Su, T
    Lipinskas, TW
    Ding, XX
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 340 (02) : 208 - 214
  • [7] Targeted disruption of the olfactory mucosa-specific Cyp2g1 gene:: Impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective effects on Cyp2a5 expression
    Zhuo, XL
    Gu, J
    Behr, MJ
    Swiatek, PJ
    Cui, HD
    Zhang, QY
    Xie, YQ
    Collins, DN
    Ding, XX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02): : 719 - 728
  • [8] Role of CYP2A5 in the metabolism of nicotine and cotinine: insights from a Cyp2a5-null mouse model and a CYP2A6-humanized mouse model
    Zhou, Xin
    Zhuo, Xiaoliang
    Xie, Fang
    Kluetzman, Kerri
    Shu, Yue-Zhong
    Humphreys, William
    Ding, Xinxin
    DRUG METABOLISM REVIEWS, 2009, 41 : 27 - 28
  • [9] Respective Roles of CYP2A5 and CYP2F2 in the Bioactivation of 3-Methylindole in Mouse Olfactory Mucosa and Lung: Studies Using Cyp2a5-Null and Cyp2f2-Null Mouse Models
    Zhou, Xin
    D'Agostino, Jaime
    Li, Lei
    Moore, Chad D.
    Yost, Garold S.
    Ding, Xinxin
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 642 - 647
  • [10] Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa
    Su, T
    He, WL
    Gu, J
    Lipinskas, TW
    Ding, XX
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (08) : 822 - 824